
IonQ Falls 5% as $2 Billion Stock Sale Fuels Dilution Concerns
IonQ dropped 5% to $23.59 after a $2 billion equity offering and the $1.15 billion Elisity deal swelled its share count to 464.7 million, capping a 30% six-session slide.
- By
- Grace Kim
- Filed
- Channel
- Tech Business
- Read
- 4 min read
IonQ shares fell 5% to $23.59 in midday trading, extending a losing streak that has wiped out 30% of the stock's value across six straight sessions through the November 17 close. That close of $24.84 marked a one-year low for the quantum computing company. The decline continued even as IonQ posted record quarterly revenue and raised full-year guidance.
The pressure traces directly to shareholder dilution. IonQ closed a $2 billion equity offering on October 16, lifting its pro forma cash position to $3.7 billion. On November 4, the company completed its acquisition of cybersecurity firm Elisity, paying $1.15 billion in stock plus an earnout of up to $150 million. Both moves expanded IonQ's share count, which now stands at 464,696,000 shares.
How IonQ's Stock Sale Fed Dilution Worries
Management framed the raise as long-term funding rather than a response to any pressing need. During IonQ's November 5 earnings call, CFO and COO Inder Singh said: "It is for long-term capital, not for any particular need." Singh added that the company completed the offering at a premium to the share price.
Investors have not been persuaded. The math of a larger share count has weighed on the stock as the selling stretched on, and the dilution debate could keep pressure on shares until it settles.
IonQ's Growth Story Still Runs Hot
The fundamental picture complicates the bear case. IonQ's third-quarter revenue reached $173.83 million, up 336% year over year and well ahead of the $141.2 million consensus estimate. Executives lifted full-year 2026 revenue guidance to between $505 million and $515 million. Remaining performance obligations, a measure of contracted backlog, more than doubled to $1.2 billion.
Acquisitions supplied a meaningful share of that growth, which makes IonQ's organic growth harder to judge:
- SkyWater Technology, acquired on July 31, contributed $83.5 million through the SkyWater Foundry Services segment.
- The IonQ Platform segment grew 127% to $90.3 million.
Profitability remains further off. Under GAAP, IonQ booked third-quarter net income of $563.96 million, but a non-cash $896.16 million warrant liability gain drove that result. On an operating basis the quarter looked weaker: adjusted EBITDA loss widened to $133.61 million from $48.91 million a year earlier, and the company reported a $433.1 million loss from operations.
How Are Quantum Peers Trading?
Pure-play quantum names moved lower alongside IonQ, though by smaller margins:
- D-Wave Quantum (NYSE: QBTS) traded at $7.85, down 3%.
- Rigetti Computing (NASDAQ: RGTI) traded at $8.39, down 0.8%, holding up best of the featured trio.
- Quantum Computing Inc. (NASDAQ: QUBT) fell 1% to $5.07.
D-Wave sits in an unusual position as both an IonQ competitor and a SkyWater foundry customer under an extended multi-year manufacturing agreement.
How Does IonQ's Model Differ From Rivals?
IonQ runs a vertically integrated trapped-ion platform, selling its Tempo and Superion systems while its SkyWater foundry manufactures chips for IonQ and outside customers. The Elisity and Nexus Photonics deals push the portfolio into Zero Trust security and integrated photonics, giving IonQ revenue streams beyond quantum computers.
D-Wave centers its commercial business on annealing systems built for optimization problems, with gate-model machines further out on its roadmap. Rigetti focuses on superconducting gate-model computers, fabricating chips in-house and drawing revenue from system sales, cloud access and government research contracts. Quantum Computing Inc. anchors its approach in photonics designed to run at room temperature.
Why Are Rate Expectations Adding Pressure?
Macro headwinds compound the dilution story. New York Fed President John Williams said on November 17 that surging AI investment could argue for more rate hikes next year, a drag for speculative growth stocks like the quantum names.
What Comes Next for IonQ?
The next test is whether the cash from the $2 billion offering converts into revenue and margin gains fast enough to justify the larger share count. Bulls point to sold-out 2027 capacity for Superion systems and IonQ's advance to Stage C of the DARPA Quantum Benchmarking Initiative, a program worth up to $300 million. Bears cite the $433.1 million operating loss and a track record of stock-funded deals, and rising rate expectations keep the dilution debate front and center until the numbers settle it.
Source: 247wallst.com
More from Grace Kim
Show full bio
Market editor covering people, launches and day-to-day practice in Semiconductors, chip manufacturing, hardware, AI compute at Chip Dispatch.
1,130 articles
Related articles
ionq-falls-8-as-quantum-stocks-slide-after-record-quarter
IonQ Falls 8% as Quantum Stocks Slide After Record Quarter
ionq-raises-revenue-outlook-to-515-million-and-lifts-peers
IonQ Raises 2026 Revenue Outlook to $515 Million and Lifts Peers
infleqtion-jumps-19-5-as-ionq-lifts-quantum-stocks
Infleqtion jumps 19.5% as IonQ lifts quantum stocks
ionq-jumps-23-to-32-62-after-173-8m-q3-raised-guide
IonQ Jumps 23% to $32.62 After $173.8M Q3, Raised 2026 Guide


